Global CRO footprint Emerald Clinical operates across 40+ countries with 70+ locations and a 25+ year track record, enabling scalable collaborations with multinational pharma and biotech clients seeking end-to-end trial solutions.

Clinical leadership Recent leadership move appointing a Global Head of Oncology signals a strategic emphasis on oncology, creating an opening for partnerships in clinical development, regulatory strategy, and specialized trial design in cancer therapies.

Awards and credibility The 2026 Asia Pacific Biopharma Excellence Award for Outstanding Patient Recruitment & Engagement enhances credibility with sponsors and may lower sales cycles for trials requiring complex patient recruitment and retention strategies.

Financial scale With annual revenue in the high hundreds of millions and a sizable workforce, Emerald Clinical can support large-scale Phase I–IV programs, offering established operational capacity to sponsors expanding trial portfolios.

Therapy focus Strong expertise in Renal, Oncology, Autoimmune, Ophthalmology, Cardiometabolic, and Early Phase development aligns with growing sponsor demand in high-value therapeutic areas, presenting targeted cross-sell opportunities for investigative sites, data management, and real-world studies.